Circa Group AS

Report Publication Announcement • Feb 26, 2021

Circa Group AS to host online presentation in connection with the first day of trading

Circa Group AS to host online presentation in connection with the first day of trading

Circa Group has the pleasure of inviting you to a company presentation on Monday 1 March at 11:00 am CET, ahead of the first day of trading on Euronext Growth on Tuesday 2 March.

Circa Group has successfully raised gross proceeds of NOK 575 million in relation to the Euronext Growth listing. The net proceeds from capital raise will be used to fund the construction of the ReSolute plant in France, while the remaining net proceeds will be used for further market development, development of new products, corporate costs and current operations.

Circa is a biotechnology company established in 2006 with the vision to produce and sell unique and highly valuable biochemicals at scale. In 2009, Circa patented the Furacell production technology, which uses abundant and renewable biomass waste to produce the highly privileged biomolecule Levoglucosenone (LGO). In 2020, Circa was granted a EU Flagship Horizon 2020 grant to support the construction of a 1,000 tonnes production facility in France (ReSolute), which represents the first step on a high-trajectory growth path towards commercial scale. ReSolute will produce Cyrene™, which is a novel biobased solvent that can replace existing, toxic and fossil-based solvent like NMP, DMF, DMSO and DCM. Global chemicals distribution giant, Merck KGaA, has already provided a Letter of Intent covering the entire Cyrene™ production capacity of the ReSolute plant. Other chemicals distribution companies have provided similar letters.

Participants:

Tony Duncan, CEO

Jason Camp, CTO

Peter Gome, CFO

Jim Henneberry, Director

Ebbe Dommisse, COO

To take part, please use the following link: https://attendee.gotowebinar.com/register/4434298922190002704

or +47 21 93 37 39 Norway, Oslo (Toll) | PIN: 410-952-831